Products Pipeline

Hikurangi Bioactives currently has eleven R&D programmes in progress with five universities, three private research institutions, four government agencies and two private companies.

Recent research by Hikurangi Bioactives has found very exciting genetic targets in samples of our plant and fungi extracts.

We have isolated a terrestrial compound with antibacterial effect against MRSA and another shows promise of being a new source for a Silent Information Regulator. We have a 50% stake in three products in pilot clinical trials this year and another two major research projects underway with extracts showing promise of breakthrough discoveries in the next two years.

HBLP Product Pipeline 2017